Quantumzyme Corp. (OTC: QTZM), a biotransformation company focused on sustainable pharmaceutical manufacturing, today announced a breakthrough advancement in its proprietary enzyme development ...
Market valued at $16.86B in 2024, projected 4.20% CAGR growth driven by VOC regulation compliance, bio-based adoption, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results